Impact of Longevity Interventions on a Validated Mouse Clinical Frailty Index

Impact of Longevity Interventions on a Validated Mouse Clinical Frailty Index
复制标题

长寿干预对经验证的小鼠临床虚弱指数的影响

DOI:
10.1093/gerona/glu315
复制
发表时间:
2016-03-01
影响因子:
5.1
通讯作者:
Mitchell, Sarah J.
Mitchell, Sarah J.
中科院分区:
医学1区
文献类型:
--
作者:
Kane, Alice E.;Hilmer, Sarah N.;Mitchell, Sarah J.

文献摘要

被引文献

相似文献

本文研究了已知影响小鼠寿命和健康寿命的因素对小鼠虚弱指数(FI)的影响:品系(短寿命DBA/2 J小鼠与长寿命C57 BL/6 J小鼠),卡路里限制(CR)和白藜芦醇治疗。基于缺陷累积的小鼠FI最近由Whitehead JC,Hildebrand BA,Sun M等人在C57 BL/6 J小鼠中验证(A clinical frailty index in aging mice:comparison with frailty index data in humans.老年人生物科学与医学杂志. 2014;69:621-632),并且与人FI具有许多特征。在自由采食和CR DBA/2 J和C57 BL/6 J小鼠中测量雄性和雌性年龄(18个月)的FI评分,以及在饮食中自由采食或不含白藜芦醇(100 mg/kg/天)的雄性年龄(24个月)的C57 BL/6 J小鼠6个月。使用两名评定者的平均评分,评定者具有良好的评定者间可靠性(ICC = 0.88,95% CI [0.80,0.92])。此外,与年龄匹配的对照组相比,CR和白藜芦醇的干预与C57 BL/6 J小鼠的FI评分显著降低相关。对于雄性热量限制组,短寿命DBA/2 J小鼠的FI评分也略高于C57 BL/6 J小鼠(DBA/2 J FI = 0.16 +/- 0.03,C57 BL/6 J FI = 0.11 +/- 0.03,p = 0.01)。本研究使用由Whitehead JC、Hildebrand BA、Sun M等人开发的小鼠FI(A clinical frailty index in aging mice:comparison with frailty index data in humans.老年学生物科学医学科学杂志二〇一四年69:621-632),并显示该工具可用于量化饮食和药物干预对虚弱的影响。
This article investigates the effect on the mouse frailty index (FI), of factors known to influence lifespan and healthspan in mice: strain (short-lived DBA/2J mice vs long-lived C57BL/6J mice), calorie restriction (CR), and resveratrol treatment. The mouse FI, based on deficit accumulation, was recently validated in C57BL/6J mice by Whitehead JC, Hildebrand BA, Sun M, et al. (A clinical frailty index in aging mice: comparisons with frailty index data in humans. J Gerontol A Biol Sci Med Sci. 2014;69:621-632) and shares many characteristics of the human FI. FI scores were measured in male and female aged (18 months) ad-libitum fed and CR DBA/2J and C57BL/6J mice, as well as male aged (24 months) C57BL/6J mice ad-libitum fed with or without resveratrol (100 mg/kg/day) in the diet for 6 months. Mean scores of two raters were used, and the raters had excellent inter-rater reliability (ICC = 0.88, 95% CI [0.80, 0.92]). Furthermore, the interventions of CR and resveratrol were associated with a significant reduction in FI scores in C57BL/6J mice, compared to age-matched controls. The short-lived DBA/2J mice also had slightly higher FI scores than the C57BL/6J mice, for the male calorie-restricted groups (DBA/2J FI = 0.16 +/- 0.03, C57BL/6J FI = 0.11 +/- 0.03, p = .01). This study uses the mouse FI developed by Whitehead JC, Hildebrand BA, Sun M, et al. (A clinical frailty index in aging mice: comparisons with frailty index data in humans. J Gerontol A Biol Sci Med Sci. 2014;69:621-632) in a different mouse colony and shows that this tool can be applied to quantify the effect of dietary and pharmaceutical interventions on frailty.